Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Literature DB >> 6309661

Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

A Imaizumi, Y Suzuki, S Ono, H Sato, Y Sato.

Abstract

The effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin (Me beta CD) on the production of pertussis toxin was evaluated. The addition of Me beta CD to the medium stimulated cell growth and pertussis toxin production. Me beta CD enhanced pertussis toxin production 100 times more in synthetic media, such as Stainer-Scholte medium (D. W. Stainer and M. J. Scholte, J. Gen. Microbiol. 63:211-220), than in Me beta CD-free medium in 2-day shake cultures. Maximum production of pertussis toxin was estimated as 50 mg of protein per liter of culture broth both by in vitro and in vivo assays. Purified toxin was demonstrated to be biochemically and biologically identical to the toxin produced in Me beta CD-free static cultures.

Entities: Chemical

Mesh：

Substances：

Year: 1983 PMID： 6309661 PMCID： PMC264618 DOI： 10.1128/iai.41.3.1138-1143.1983

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

13 in total

1. The growth of Bordetella pertussis: a review.

Authors: E ROWATT
Journal: J Gen Microbiol Date: 1957-10

2. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors: R A REISFELD; U J LEWIS; D E WILLIAMS
Journal: Nature Date: 1962-07-21 Impact factor: 49.962

3. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.

Authors: L I Irons; A P MacLennan
Journal: Biochim Biophys Acta Date: 1979-09-29

Review 4. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors: M Pittman
Journal: Rev Infect Dis Date: 1979 May-Jun

5. Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis.

Authors: M Yajima; K Hosoda; Y Kanbayashi; T Nakamura; I Takahashi; M Ui
Journal: J Biochem Date: 1978-01 Impact factor: 3.387

6. A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors: D W Stainer; M J Scholte
Journal: J Gen Microbiol Date: 1970-10

7. Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis.

Authors: S B Lehrer; E M Tan; J H Vaughan
Journal: J Immunol Date: 1974-07 Impact factor: 5.422

8. Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.

Authors: A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal: J Clin Microbiol Date: 1983-05 Impact factor: 5.948

9. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors: J J Munoz; H Arai; R L Cole
Journal: Infect Immun Date: 1981-04 Impact factor: 3.441

10. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.

Authors: S I Morse; J H Morse
Journal: J Exp Med Date: 1976-06-01 Impact factor: 14.307

34 in total

1. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors: S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal: Infect Immun Date: 1990-11 Impact factor: 3.441

2. Promoter of the pertussis toxin operon and production of pertussis toxin.

Authors: A Nicosia; R Rappuoli
Journal: J Bacteriol Date: 1987-06 Impact factor: 3.490

3. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations.

Authors: C K Lee; A L Roberts; T M Finn; S Knapp; J J Mekalanos
Journal: Infect Immun Date: 1990-08 Impact factor: 3.441

4. Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.

Authors: C H von Koenig; A Tacken; H Finger
Journal: J Clin Microbiol Date: 1988-12 Impact factor: 5.948

5. Effects of transport temperature and medium on recovery of Bordetella pertussis from nasopharyngeal swabs.

Authors: W E Morrill; J M Barbaree; B S Fields; G N Sanden; W T Martin
Journal: J Clin Microbiol Date: 1988-09 Impact factor: 5.948

6. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.

Authors: G Renauld-Mongénie; N Mielcarek; J Cornette; A M Schacht; A Capron; G Riveau; C Locht
Journal: Proc Natl Acad Sci U S A Date: 1996-07-23 Impact factor: 11.205

7. Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.

Authors: A Suarez; L H Staendner; M Rohde; G Piatti; K N Timmis; C A Guzmán
Journal: Appl Environ Microbiol Date: 1997-01 Impact factor: 4.792

8. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.

Authors: R Antoine; C Locht
Journal: Infect Immun Date: 1990-06 Impact factor: 3.441

9. Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.

Authors: S K Skelton; K H Wong
Journal: J Clin Microbiol Date: 1990-05 Impact factor: 5.948

10. Expression of BfrH, a putative siderophore receptor of Bordetella bronchiseptica, is regulated by iron, Fur1, and the extracellular function sigma factor EcfI.

Authors: Jonathan M Burgos; Natalie D King-Lyons; Terry D Connell
Journal: Infect Immun Date: 2009-12-14 Impact factor: 3.441